1-ethyl-3-[6-(5-ethyl-4-methyl-6-oxo-1H-pyridin-2-yl)-4-pyrazol-1-yl-1H-benzimidazol-2-yl]urea;1-ethyl-3-[6-(1-methyl-2-oxo-4-pyridinyl)-4-pyridin-2-yl-1H-benzimidazol-2-yl]urea;1-ethyl-3-[6-(5-oxo-2,3-dihydro-1H-indolizin-7-yl)-4-pyrazol-1-yl-1H-benzimidazol-2-yl]urea

C63H64N20O6 — CID 157319531

IUPAC1-ethyl-3-[6-(5-ethyl-4-methyl-6-oxo-1H-pyridin-2-yl)-4-pyrazol-1-yl-1H-benzimidazol-2-yl]urea;1-ethyl-3-[6-(1-methyl-2-oxo-4-pyridinyl)-4-pyridin-2-yl-1H-benzimidazol-2-yl]urea;1-ethyl-3-[6-(5-oxo-2,3-dihydro-1H-indolizin-7-yl)-4-pyrazol-1-yl-1H-benzimidazol-2-yl]urea
SMILESCCNC(=O)Nc1nc2c(-c3ccccn3)cc(-c3ccn(C)c(=O)c3)cc2[nH]1.CCNC(=O)Nc1nc2c(-n3cccn3)cc(-c3cc(C)c(CC)c(=O)[nH]3)cc2[nH]1.CCNC(=O)Nc1nc2c(-n3cccn3)cc(-c3cc4n(c(=O)c3)CCC4)cc2[nH]1
InChIInChI=1S/C21H21N7O2.C21H23N7O2.C21H20N6O2/c1-2-22-21(30)26-20-24-16-10-14(11-17(19(16)25-20)28-8-4-6-23-28)13-9-15-5-3-7-27(15)18(29)12-13;1-4-14-12(3)9-15(24-19(14)29)13-10-16-18(17(11-13)28-8-6-7-23-28)26-20(25-16)27-21(30)22-5-2;1-3-22-21(29)26-20-24-17-11-14(13-7-9-27(2)18(28)12-13)10-15(19(17)25-20)16-6-4-5-8-23-16/h4,6,8-12H,2-3,5,7H2,1H3,(H3,22,24,25,26,30);6-11H,4-5H2,1-3H3,(H,24,29)(H3,22,25,26,27,30);4-12H,3H2,1-2H3,(H3,22,24,25,26,29)
InChIKeyBDZONJYIDCMNBH-UHFFFAOYSA-N
MW1197.34 g/mol
LogP8.91
Rot. Bonds13

About 1-ethyl-3-[6-(5-ethyl-4-methyl-6-oxo-1H-pyridin-2-yl)-4-pyrazol-1-yl-1H-benzimidazol-2-yl]urea;1-ethyl-3-[6-(1-methyl-2-oxo-4-pyridinyl)-4-pyridin-2-yl-1H-benzimidazol-2-yl]urea;1-ethyl-3-[6-(5-oxo-2,3-dihydro-1H-indolizin-7-yl)-4-pyrazol-1-yl-1H-benzimidazol-2-yl]urea

1-ethyl-3-[6-(5-ethyl-4-methyl-6-oxo-1H-pyridin-2-yl)-4-pyrazol-1-yl-1H-benzimidazol-2-yl]urea;1-ethyl-3-[6-(1-methyl-2-oxo-4-pyridinyl)-4-pyridin-2-yl-1H-benzimidazol-2-yl]urea;1-ethyl-3-[6-(5-oxo-2,3-dihydro-1H-indolizin-7-yl)-4-pyrazol-1-yl-1H-benzimidazol-2-yl]urea (PubChem CID 157319531) has the molecular formula C63H64N20O6 and a molecular weight of 1197.34 g/mol. Its IUPAC name is 1-ethyl-3-[6-(5-ethyl-4-methyl-6-oxo-1H-pyridin-2-yl)-4-pyrazol-1-yl-1H-benzimidazol-2-yl]urea;1-ethyl-3-[6-(1-methyl-2-oxo-4-pyridinyl)-4-pyridin-2-yl-1H-benzimidazol-2-yl]urea;1-ethyl-3-[6-(5-oxo-2,3-dihydro-1H-indolizin-7-yl)-4-pyrazol-1-yl-1H-benzimidazol-2-yl]urea.

Molecular Properties

Compound Name1-ethyl-3-[6-(5-ethyl-4-methyl-6-oxo-1H-pyridin-2-yl)-4-pyrazol-1-yl-1H-benzimidazol-2-yl]urea;1-ethyl-3-[6-(1-methyl-2-oxo-4-pyridinyl)-4-pyridin-2-yl-1H-benzimidazol-2-yl]urea;1-ethyl-3-[6-(5-oxo-2,3-dihydro-1H-indolizin-7-yl)-4-pyrazol-1-yl-1H-benzimidazol-2-yl]urea
PubChem CID157319531
Molecular FormulaC63H64N20O6
Molecular Weight1197.34 g/mol
Exact Mass1196.53
IUPAC Name1-ethyl-3-[6-(5-ethyl-4-methyl-6-oxo-1H-pyridin-2-yl)-4-pyrazol-1-yl-1H-benzimidazol-2-yl]urea;1-ethyl-3-[6-(1-methyl-2-oxo-4-pyridinyl)-4-pyridin-2-yl-1H-benzimidazol-2-yl]urea;1-ethyl-3-[6-(5-oxo-2,3-dihydro-1H-indolizin-7-yl)-4-pyrazol-1-yl-1H-benzimidazol-2-yl]urea
SMILESCCNC(=O)Nc1nc2c(-c3ccccn3)cc(-c3ccn(C)c(=O)c3)cc2[nH]1.CCNC(=O)Nc1nc2c(-n3cccn3)cc(-c3cc(C)c(CC)c(=O)[nH]3)cc2[nH]1.CCNC(=O)Nc1nc2c(-n3cccn3)cc(-c3cc4n(c(=O)c3)CCC4)cc2[nH]1
InChIInChI=1S/C21H21N7O2.C21H23N7O2.C21H20N6O2/c1-2-22-21(30)26-20-24-16-10-14(11-17(19(16)25-20)28-8-4-6-23-28)13-9-15-5-3-7-27(15)18(29)12-13;1-4-14-12(3)9-15(24-19(14)29)13-10-16-18(17(11-13)28-8-6-7-23-28)26-20(25-16)27-21(30)22-5-2;1-3-22-21(29)26-20-24-17-11-14(13-7-9-27(2)18(28)12-13)10-15(19(17)25-20)16-6-4-5-8-23-16/h4,6,8-12H,2-3,5,7H2,1H3,(H3,22,24,25,26,30);6-11H,4-5H2,1-3H3,(H,24,29)(H3,22,25,26,27,30);4-12H,3H2,1-2H3,(H3,22,24,25,26,29)
InChIKeyBDZONJYIDCMNBH-UHFFFAOYSA-N
XLogP8.91
TPSA334.82 Ų
H-Bond Donors10
H-Bond Acceptors16
Rotatable Bonds13
Heavy Atoms89
Complexity

Lipinski Rule of Five

4 violations

RuleValue
MW ≤ 5001197.34
LogP ≤ 58.91
H-Bond Donors ≤ 510
H-Bond Acceptors ≤ 1016

Analyze 1-ethyl-3-[6-(5-ethyl-4-methyl-6-oxo-1H-pyridin-2-yl)-4-pyrazol-1-yl-1H-benzimidazol-2-yl]urea;1-ethyl-3-[6-(1-methyl-2-oxo-4-pyridinyl)-4-pyridin-2-yl-1H-benzimidazol-2-yl]urea;1-ethyl-3-[6-(5-oxo-2,3-dihydro-1H-indolizin-7-yl)-4-pyrazol-1-yl-1H-benzimidazol-2-yl]urea with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Frequently Asked Questions

What is the IUPAC name of 1-ethyl-3-[6-(5-ethyl-4-methyl-6-oxo-1H-pyridin-2-yl)-4-pyrazol-1-yl-1H-benzimidazol-2-yl]urea;1-ethyl-3-[6-(1-methyl-2-oxo-4-pyridinyl)-4-pyridin-2-yl-1H-benzimidazol-2-yl]urea;1-ethyl-3-[6-(5-oxo-2,3-dihydro-1H-indolizin-7-yl)-4-pyrazol-1-yl-1H-benzimidazol-2-yl]urea?
The IUPAC name of 1-ethyl-3-[6-(5-ethyl-4-methyl-6-oxo-1H-pyridin-2-yl)-4-pyrazol-1-yl-1H-benzimidazol-2-yl]urea;1-ethyl-3-[6-(1-methyl-2-oxo-4-pyridinyl)-4-pyridin-2-yl-1H-benzimidazol-2-yl]urea;1-ethyl-3-[6-(5-oxo-2,3-dihydro-1H-indolizin-7-yl)-4-pyrazol-1-yl-1H-benzimidazol-2-yl]urea (CID 157319531) is 1-ethyl-3-[6-(5-ethyl-4-methyl-6-oxo-1H-pyridin-2-yl)-4-pyrazol-1-yl-1H-benzimidazol-2-yl]urea;1-ethyl-3-[6-(1-methyl-2-oxo-4-pyridinyl)-4-pyridin-2-yl-1H-benzimidazol-2-yl]urea;1-ethyl-3-[6-(5-oxo-2,3-dihydro-1H-indolizin-7-yl)-4-pyrazol-1-yl-1H-benzimidazol-2-yl]urea.
What is the SMILES notation for 1-ethyl-3-[6-(5-ethyl-4-methyl-6-oxo-1H-pyridin-2-yl)-4-pyrazol-1-yl-1H-benzimidazol-2-yl]urea;1-ethyl-3-[6-(1-methyl-2-oxo-4-pyridinyl)-4-pyridin-2-yl-1H-benzimidazol-2-yl]urea;1-ethyl-3-[6-(5-oxo-2,3-dihydro-1H-indolizin-7-yl)-4-pyrazol-1-yl-1H-benzimidazol-2-yl]urea?
The canonical SMILES for 1-ethyl-3-[6-(5-ethyl-4-methyl-6-oxo-1H-pyridin-2-yl)-4-pyrazol-1-yl-1H-benzimidazol-2-yl]urea;1-ethyl-3-[6-(1-methyl-2-oxo-4-pyridinyl)-4-pyridin-2-yl-1H-benzimidazol-2-yl]urea;1-ethyl-3-[6-(5-oxo-2,3-dihydro-1H-indolizin-7-yl)-4-pyrazol-1-yl-1H-benzimidazol-2-yl]urea is CCNC(=O)Nc1nc2c(-c3ccccn3)cc(-c3ccn(C)c(=O)c3)cc2[nH]1.CCNC(=O)Nc1nc2c(-n3cccn3)cc(-c3cc(C)c(CC)c(=O)[nH]3)cc2[nH]1.CCNC(=O)Nc1nc2c(-n3cccn3)cc(-c3cc4n(c(=O)c3)CCC4)cc2[nH]1.
What is the InChIKey of 1-ethyl-3-[6-(5-ethyl-4-methyl-6-oxo-1H-pyridin-2-yl)-4-pyrazol-1-yl-1H-benzimidazol-2-yl]urea;1-ethyl-3-[6-(1-methyl-2-oxo-4-pyridinyl)-4-pyridin-2-yl-1H-benzimidazol-2-yl]urea;1-ethyl-3-[6-(5-oxo-2,3-dihydro-1H-indolizin-7-yl)-4-pyrazol-1-yl-1H-benzimidazol-2-yl]urea?
The InChIKey is BDZONJYIDCMNBH-UHFFFAOYSA-N. The full InChI is InChI=1S/C21H21N7O2.C21H23N7O2.C21H20N6O2/c1-2-22-21(30)26-20-24-16-10-14(11-17(19(16)25-20)28-8-4-6-23-28)13-9-15-5-3-7-27(15)18(29)12-13;1-4-14-12(3)9-15(24-19(14)29)13-10-16-18(17(11-13)28-8-6-7-23-28)26-20(25-16)27-21(30)22-5-2;1-3-22-21(29)26-20-24-17-11-14(13-7-9-27(2)18(28)12-13)10-15(19(17)25-20)16-6-4-5-8-23-16/h4,6,8-12H,2-3,5,7H2,1H3,(H3,22,24,25,26,30);6-11H,4-5H2,1-3H3,(H,24,29)(H3,22,25,26,27,30);4-12H,3H2,1-2H3,(H3,22,24,25,26,29).
What are the key properties of 1-ethyl-3-[6-(5-ethyl-4-methyl-6-oxo-1H-pyridin-2-yl)-4-pyrazol-1-yl-1H-benzimidazol-2-yl]urea;1-ethyl-3-[6-(1-methyl-2-oxo-4-pyridinyl)-4-pyridin-2-yl-1H-benzimidazol-2-yl]urea;1-ethyl-3-[6-(5-oxo-2,3-dihydro-1H-indolizin-7-yl)-4-pyrazol-1-yl-1H-benzimidazol-2-yl]urea?
1-ethyl-3-[6-(5-ethyl-4-methyl-6-oxo-1H-pyridin-2-yl)-4-pyrazol-1-yl-1H-benzimidazol-2-yl]urea;1-ethyl-3-[6-(1-methyl-2-oxo-4-pyridinyl)-4-pyridin-2-yl-1H-benzimidazol-2-yl]urea;1-ethyl-3-[6-(5-oxo-2,3-dihydro-1H-indolizin-7-yl)-4-pyrazol-1-yl-1H-benzimidazol-2-yl]urea has a molecular weight of 1197.34 g/mol, XLogP of 8.91, 13 rotatable bonds, 10 hydrogen bond donors, and 16 hydrogen bond acceptors.
Where does this data come from?
All data for 1-ethyl-3-[6-(5-ethyl-4-methyl-6-oxo-1H-pyridin-2-yl)-4-pyrazol-1-yl-1H-benzimidazol-2-yl]urea;1-ethyl-3-[6-(1-methyl-2-oxo-4-pyridinyl)-4-pyridin-2-yl-1H-benzimidazol-2-yl]urea;1-ethyl-3-[6-(5-oxo-2,3-dihydro-1H-indolizin-7-yl)-4-pyrazol-1-yl-1H-benzimidazol-2-yl]urea is sourced from PubChem (CID 157319531), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).